Proteus Syndrome: Description of Two Clinical Cases

Background . Proteus syndrome is extremely rare congenital multisystem disease with high variability in clinical manifestations. Its prevalence is unknown, there are less than 200 cases in the world literature. The syndrome is a classic example of somatic mosaicism, and all target drugs for its management are based on it. Clinical case description. This article describes two clinical cases with somatic variants of the nucleotide sequence in the AKT1 gene, mosaic form, revealed by the NGS method. Target drug (mTOR-inhibitors group) was assigned in one case. Conclusion . The description of the phenotypic features of patients with Proteus syndrome is crucial as this pathology is very rare. It is necessary to increase the awareness of clinicians about this disease to develop a plan for dynamic follow-up with consideration to life-threatening complications (malignant tumors and thrombembolia risk). Genetic verification of Proteus syndrome is mandatory nowadays as target therapy is actively developed and implemented, thus, revision of clinical guidelines is recommended.

Authors

Institutions

Publication Details

Journal
Вопросы современной педиатрии
Published
2024-10-31
DOI
https://doi.org/10.15690/vsp.v23i5.2797
Citations
1
Primary Topic
Vascular Malformations and Hemangiomas
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Proteus Syndrome: Description of Two Clinical Cases

Т. Т. Валиев, V. V. Emtsova, Nikolay N. Murashkin, G. B. Sagoyan et al.
1 citations
Вопросы современной педиатрии
Vascular Malformations and Hemangiomas
0.57
article

Proteus Syndrome: Description of Two Clinical Cases

Т. Т. Валиев, V. V. Emtsova, Nikolay N. Murashkin, G. B. Sagoyan, Е. V. Sharapova, Т. С. Белышева, E. E. Zelenova, Э. В. Кумирова, V. V. Strelnikov, В. В. Семенова, Darya Osipova, Наталя Семенова, Т. В. Наседкина, E. Yu. Bychkova
article en
1 citations

Abstract

Background . Proteus syndrome is extremely rare congenital multisystem disease with high variability in clinical manifestations. Its prevalence is unknown, there are less than 200 cases in the world literature. The syndrome is a classic example of somatic mosaicism, and all target drugs for its management are based on it. Clinical case description. This article describes two clinical cases with somatic variants of the nucleotide sequence in the AKT1 gene, mosaic form, revealed by the NGS method. Target drug (mTOR-inhibitors group) was assigned in one case. Conclusion . The description of the phenotypic features of patients with Proteus syndrome is crucial as this pathology is very rare. It is necessary to increase the awareness of clinicians about this disease to develop a plan for dynamic follow-up with consideration to life-threatening complications (malignant tumors and thrombembolia risk). Genetic verification of Proteus syndrome is mandatory nowadays as target therapy is actively developed and implemented, thus, revision of clinical guidelines is recommended.

Вопросы современной педиатрииVol. 23(5)
Engelhardt Institute of Molecular Biology (RU), Sechenov University (RU), Pirogov Russian National Research Medical University (RU), Central State Medical Academy (RU), Research Centre for Medical Genetics (RU)
Good health and well-being
Openalex Percentile: Top 28%
Vascular Malformations and Hemangiomas
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.